• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lymphoidal chemokine CCL19 promoted the heterogeneity of the breast tumor cell motility within a 3D microenvironment revealed by a Lévy distribution analysis.淋巴趋化因子 CCL19 通过 Lévy 分布分析揭示了 3D 微环境中乳腺癌细胞迁移的异质性。
Integr Biol (Camb). 2020 Feb 22;12(1):12-20. doi: 10.1093/intbio/zyaa001.
2
Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.在三维条件下,定义趋化因子梯度下的树突状细胞趋化作用揭示了对配体 CCL21 和 CCL19 的不同反应。
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5614-9. doi: 10.1073/pnas.1014920108. Epub 2011 Mar 21.
3
CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.CCR7通过诱导上皮-间质转化并通过AKT途径抑制凋亡来介导人乳腺癌细胞的侵袭和迁移。
Cancer Med. 2017 May;6(5):1062-1071. doi: 10.1002/cam4.1039. Epub 2017 Apr 4.
4
Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber.可调式 3D 间质流室中乳腺癌细胞的迁移动态。
Integr Biol (Camb). 2012 Apr;4(4):401-9. doi: 10.1039/c1ib00128k. Epub 2011 Dec 5.
5
Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.趋化因子(C-C基序)受体7的唾液酸化抑制可抑制CCL19刺激的增殖、侵袭及抗失巢凋亡作用。
PLoS One. 2014 Jun 10;9(6):e98823. doi: 10.1371/journal.pone.0098823. eCollection 2014.
6
Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.荧光标记的 CCL19 和 CCL21 用于监测 CCR7 和 ACKR4 功能。
Int J Mol Sci. 2018 Dec 4;19(12):3876. doi: 10.3390/ijms19123876.
7
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.基于 CCR7/CCL19 趋化因子轴作为乳腺癌生物标志物的 ceRNA 预后模型的构建。
BMC Med Genomics. 2023 Oct 21;16(1):254. doi: 10.1186/s12920-023-01683-9.
8
CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.CCL19 与 CCL21 尾缀融合后增强了糖胺聚糖结合能力,同时保持了对树突状细胞的趋化活性。
J Leukoc Biol. 2018 Aug;104(2):401-411. doi: 10.1002/JLB.2VMA0118-008R. Epub 2018 May 16.
9
Human breast cancer-derived soluble factors facilitate CCL19-induced chemotaxis of human dendritic cells.人乳腺癌来源的可溶性因子促进CCL19诱导的人树突状细胞趋化。
Sci Rep. 2016 Jul 25;6:30207. doi: 10.1038/srep30207.
10
Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.趋化因子受体7通过激活基质金属蛋白酶-9增强头颈部转移性鳞状细胞癌的细胞趋化性和迁移能力。
Oncol Rep. 2014 Aug;32(2):794-800. doi: 10.3892/or.2014.3242. Epub 2014 Jun 6.

引用本文的文献

1
The expression and prognostic value of CCL19 in breast cancer.CCL19在乳腺癌中的表达及预后价值
Discov Oncol. 2025 May 20;16(1):830. doi: 10.1007/s12672-025-02715-9.
2
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.基于 CCR7/CCL19 趋化因子轴作为乳腺癌生物标志物的 ceRNA 预后模型的构建。
BMC Med Genomics. 2023 Oct 21;16(1):254. doi: 10.1186/s12920-023-01683-9.
3
Does CCL19 act as a double-edged sword in cancer development?CCL19 是否在癌症发展中充当双刃剑?
Clin Exp Immunol. 2022 Apr 4;207(2):164-175. doi: 10.1093/cei/uxab039.
4
Multifaceted role of chemokines in solid tumors: From biology to therapy.趋化因子在实体瘤中的多效性作用:从生物学到治疗。
Semin Cancer Biol. 2022 Nov;86(Pt 3):1105-1121. doi: 10.1016/j.semcancer.2021.12.011. Epub 2022 Jan 1.
5
Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications.重新思考脑转移中的趋化因子级联反应:预防和治疗意义。
Semin Cancer Biol. 2022 Nov;86(Pt 3):914-930. doi: 10.1016/j.semcancer.2021.12.009. Epub 2021 Dec 27.

本文引用的文献

1
Lévy-like movement patterns of metastatic cancer cells revealed in microfabricated systems and implicated in vivo.微制造系统中揭示的转移性癌细胞的 Lévy 样运动模式及其在体内的作用。
Nat Commun. 2018 Oct 31;9(1):4539. doi: 10.1038/s41467-018-06563-w.
2
Swarming bacteria migrate by Lévy Walk.群体游动细菌通过列维游走进行迁移。
Nat Commun. 2015 Sep 25;6:8396. doi: 10.1038/ncomms9396.
3
Three-dimensional cell migration does not follow a random walk.三维细胞迁移不遵循随机游走。
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):3949-54. doi: 10.1073/pnas.1318967111. Epub 2014 Mar 4.
4
Modeling tumor microenvironments in vitro.体外模拟肿瘤微环境。
J Biomech Eng. 2014 Feb;136(2):021011. doi: 10.1115/1.4026447.
5
Cooperative roles of SDF-1α and EGF gradients on tumor cell migration revealed by a robust 3D microfluidic model.SDF-1α 和 EGF 浓度梯度在肿瘤细胞迁移中的协同作用通过稳健的 3D 微流控模型揭示。
PLoS One. 2013 Jul 15;8(7):e68422. doi: 10.1371/journal.pone.0068422. Print 2013.
6
Guidance of cell migration by substrate dimension.基质维度对细胞迁移的指导作用。
Biophys J. 2013 Jan 22;104(2):313-21. doi: 10.1016/j.bpj.2012.12.001.
7
Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells.广义 Lévy 游走与趋化因子在效应性 CD8+T 细胞迁移中的作用。
Nature. 2012 Jun 28;486(7404):545-8. doi: 10.1038/nature11098.
8
Microfluidics for mammalian cell chemotaxis.微流控技术在哺乳动物细胞趋化性中的应用。
Ann Biomed Eng. 2012 Jun;40(6):1316-27. doi: 10.1007/s10439-011-0489-9. Epub 2011 Dec 22.
9
Interaction of tumor cells and lymphatic vessels in cancer progression.肿瘤细胞与淋巴管在癌症进展中的相互作用。
Oncogene. 2012 Oct 18;31(42):4499-508. doi: 10.1038/onc.2011.602. Epub 2011 Dec 19.
10
Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber.可调式 3D 间质流室中乳腺癌细胞的迁移动态。
Integr Biol (Camb). 2012 Apr;4(4):401-9. doi: 10.1039/c1ib00128k. Epub 2011 Dec 5.

淋巴趋化因子 CCL19 通过 Lévy 分布分析揭示了 3D 微环境中乳腺癌细胞迁移的异质性。

Lymphoidal chemokine CCL19 promoted the heterogeneity of the breast tumor cell motility within a 3D microenvironment revealed by a Lévy distribution analysis.

机构信息

Department of Biological and Environmental Engineering, Cornell University, Ithaca, NY, USA.

Department of Food Engineering, King Mongkut's Institute of Technology, Bangkok, Thailand.

出版信息

Integr Biol (Camb). 2020 Feb 22;12(1):12-20. doi: 10.1093/intbio/zyaa001.

DOI:10.1093/intbio/zyaa001
PMID:32055833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036475/
Abstract

Tumor cell heterogeneity, either at the genotypic or the phenotypic level, is a hallmark of cancer. Tumor cells exhibit large variations, even among cells derived from the same origin, including cell morphology, speed and motility type. However, current work for quantifying tumor cell behavior is largely population based and does not address the question of cell heterogeneity. In this article, we utilize Lévy distribution analysis, a method known in both social and physical sciences for quantifying rare events, to characterize the heterogeneity of tumor cell motility. Specifically, we studied the breast tumor cell (MDA-MB-231 cell line) velocity statistics when the cells were subject to well-defined lymphoid chemokine (CCL19) gradients using a microfluidic platform. Experimental results showed that the tail end of the velocity distribution of breast tumor cell was well described by a Lévy function. The measured Lévy exponent revealed that cell motility was more heterogeneous when CCL19 concentration was near the dynamic kinetic binding constant to its corresponding receptor CCR7. This work highlighted the importance of tumor microenvironment in modulating tumor cell heterogeneity and invasion.

摘要

肿瘤细胞异质性,无论是在基因型还是表型水平上,都是癌症的一个标志。肿瘤细胞表现出很大的变化,即使是来自同一来源的细胞之间,也包括细胞形态、速度和运动类型。然而,目前用于量化肿瘤细胞行为的工作主要是基于群体的,并没有解决细胞异质性的问题。在本文中,我们利用 Lévy 分布分析,这是一种在社会和物理科学中都用于量化稀有事件的方法,来描述肿瘤细胞运动的异质性。具体来说,我们使用微流控平台研究了在淋巴趋化因子(CCL19)梯度作用下,乳腺肿瘤细胞(MDA-MB-231 细胞系)速度统计的 Lévy 分布。实验结果表明,乳腺肿瘤细胞速度分布的尾部可以很好地用 Lévy 函数来描述。测量得到的 Lévy 指数表明,当 CCL19 浓度接近其对应受体 CCR7 的动态动力学结合常数时,细胞的运动异质性更大。这项工作强调了肿瘤微环境在调节肿瘤细胞异质性和侵袭性方面的重要性。